These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15180800)

  • 1. Steroid treatment for relapses in multiple sclerosis - the evidence urges shared decision-making.
    Köpke S; Heesen C; Kasper J; Mühlhauser I
    Acta Neurol Scand; 2004 Jul; 110(1):1-5. PubMed ID: 15180800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial.
    Köpke S; Kasper J; Mühlhauser I; Nübling M; Heesen C
    Mult Scler; 2009 Jan; 15(1):96-104. PubMed ID: 18845657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High dosage corticosteroids: in multiple sclerosis pulse therapy is of value].
    Gold R
    MMW Fortschr Med; 1999 Jun; 141(25):76-7. PubMed ID: 10897917
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic indications targeting etiology. (With the exception of primary progressive forms)].
    Brassat D
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1014-28. PubMed ID: 11787332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience.
    Pozzilli C; Prosperini L; Sbardella E; De Giglio L; Onesti E; Tomassini V
    Neurol Sci; 2005 Dec; 26 Suppl 4():S174-8. PubMed ID: 16388353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
    Havrdova E; Zivadinov R; Krasensky J; Dwyer MG; Novakova I; Dolezal O; Ticha V; Dusek L; Houzvickova E; Cox JL; Bergsland N; Hussein S; Svobodnik A; Seidl Z; Vaneckova M; Horakova D
    Mult Scler; 2009 Aug; 15(8):965-76. PubMed ID: 19465443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informed shared decision making in multiple sclerosis--inevitable or impossible?
    Heesen C; Kasper J; Köpke S; Richter T; Segal J; Mühlhauser I
    J Neurol Sci; 2007 Aug; 259(1-2):109-17. PubMed ID: 17400253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Informed decisions: patient and consumer information at the German Agency for Quality in Medicine (ÄZQ)].
    Schaefer C; Kirschning S
    Z Evid Fortbild Qual Gesundhwes; 2010; 104(7):578-84. PubMed ID: 21095611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Fazekas F; Lublin FD; Li D; Freedman MS; Hartung HP; Rieckmann P; Sørensen PS; Maas-Enriquez M; Sommerauer B; Hanna K; ;
    Neurology; 2008 Jul; 71(4):265-71. PubMed ID: 18645164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of multiple sclerosis relapses with immunomodulating agents.
    Johnson KP
    J Neurol Sci; 2007 May; 256 Suppl 1():S23-8. PubMed ID: 17350652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.
    Kappos L; Traboulsee A; Constantinescu C; Erälinna JP; Forrestal F; Jongen P; Pollard J; Sandberg-Wollheim M; Sindic C; Stubinski B; Uitdehaag B; Li D
    Neurology; 2006 Sep; 67(6):944-53. PubMed ID: 17000959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Informed decision making: what is its role in cancer screening?
    Rimer BK; Briss PA; Zeller PK; Chan EC; Woolf SH
    Cancer; 2004 Sep; 101(5 Suppl):1214-28. PubMed ID: 15316908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competing norms: Canadian rural family physicians' perceptions of clinical practice guidelines and shared decision-making.
    Boivin A; Légaré F; Gagnon MP
    J Health Serv Res Policy; 2008 Apr; 13(2):79-84. PubMed ID: 18416912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis: diagnosis and the management of acute relapses.
    Leary SM; Porter B; Thompson AJ
    Postgrad Med J; 2005 May; 81(955):302-8. PubMed ID: 15879043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of high-dose, high-frequency interferon beta-1a in relapsing-remitting multiple sclerosis are sustained to 16 months: final comparative results of the EVIDENCE trial.
    Panitch H; Goodin D; Francis G; Chang P; Coyle P; O'Connor P; Li D; Weinshenker B;
    J Neurol Sci; 2005 Dec; 239(1):67-74. PubMed ID: 16169561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results.
    Rose JW; Burns JB; Bjorklund J; Klein J; Watt HE; Carlson NG
    Neurology; 2007 Aug; 69(8):785-9. PubMed ID: 17709711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shared decision making in the medical encounter: are we all talking about the same thing?
    Moumjid N; Gafni A; Brémond A; Carrère MO
    Med Decis Making; 2007; 27(5):539-46. PubMed ID: 17873252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of relapse rate in MS clinical trials.
    Held U; Heigenhauser L; Shang C; Kappos L; Polman C;
    Neurology; 2005 Dec; 65(11):1769-73. PubMed ID: 16344520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Shared decision making].
    Floer B; Schnee M; Böcken J; Streich W; Kunstmann W; Isfort J; Butzlaff M
    Dtsch Med Wochenschr; 2004 Oct; 129(44):2343-7. PubMed ID: 15497102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.